Oxford Drug Design

Our Science


At Oxford Drug Design we leverage our knowledge of tRNA synthetases (aaRS) to rapidly advance multiple drug candidates to the clinic – promising new therapies designed to treat major diseases where this enzyme family plays a key role.

We focus on identifying novel disease targets based on the non-canonical functions of aaRS, and integrate this new biochemistry with our pioneering computational platform trained specifically on this target family.

Oxford Drug Design Ltd
Oxford Centre for Innovation
New Road
Oxford OX1 1BY, UK

+44 (0)1865 261468

© Oxford Drug Design. All Rights Reserved 2023. Legal Information. Site Design by Koma.live